AI Verdict
MSFT has stronger fundamentals based on our AI analysis.
FZMD vs MSFT Fundamental Comparison
| Metric | FZMD | MSFT |
|---|---|---|
| Revenue | $9.0M | $158.9B |
| Net Income | $79,227.0 | $66.2B |
| Net Margin | 0.9% | 41.7% |
| ROE | N/A | 16.9% |
| ROA | 0.4% | 10.0% |
| Current Ratio | 1.06x | 1.39x |
| Debt/Equity | N/A | 0.10x |
| EPS | $0.00 | $8.87 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
FZMD vs MSFT: Frequently Asked Questions
Is FZMD or MSFT a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MSFT has stronger fundamentals. FZMD is rated SELL (85% confidence) while MSFT is rated BUY (91% confidence). This is not investment advice.
How does FZMD compare to MSFT fundamentally?
Fuse Medical, Inc. has ROE of N/A vs MICROSOFT CORP's 16.9%. Net margins are 0.9% vs 41.7% respectively.
Which stock pays higher dividends, FZMD or MSFT?
FZMD has a dividend yield of N/A or no dividend while MSFT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in FZMD or MSFT for long term?
For long-term investing, consider that FZMD has SELL rating with 85% confidence, while MSFT has BUY rating with 91% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about FZMD vs MSFT?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For FZMD vs MSFT, the AI consensus favors MSFT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.